Antibiotic Resistance Implications for Global Health and Novel Intervention Strategies: Workshop Summary (2010) / Chapter Skim
Currently Skimming:
Appendix F: Speaker Biographies
Appendix F: Speaker Biographies
Pages 465-474
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 465... ...
Later he completed subspecialty training in infectious diseases at the Montefiore Medical Center and Albert Einstein College of Medicine.
|
From page 466... ...
He and his colleagues demonstrated that a wide variety of pathogenic bacteria can promiscuously exchange the genetic material conferring antibiotic resistance, proved that conjugation could account for dissemination of resistance determinants between phylogenetically remote bacterial genera, elucidated the transposition mechanism of conjugative trans posons from Gram-positive cocci, and, more recently, obtained direct gene and protein transfer from bacteria to mammalian cells. His work has been reported in more than 290 publications in international scientific journals.
|
From page 467... ...
, a national organization dedicated to preventing epidemics and protecting people. Her prior positions include execu tive director of the Pew Environmental Health Commission, a program officer at the Pew Charitable Trusts, the Acting Director of the New Jersey Department of Environmental Protection Office of Pollution Prevention, and a scientist with the Natural Resources Defense Council.
|
From page 468... ...
Laxminarayan has worked on research that integrates epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding drug resistance as a problem of managing a shared global resource, and on the appropriate design of incentives to encourage more prompt reporting of infectious disease outbreaks.
|
From page 469... ...
Dr. Lewis has been a permanent member of the Drug Discovery and Drug Resistance NIH Study Section (2004–2006)
|
From page 470... ...
In 1993–1995, he worked at CDC, where he conducted the pilot study of Project I-CARE, the CDC and Emory University joint attempt to start surveillance of antimicrobial resistance and antimicrobial use in National Nosocomial Infections Surveillance hospitals. Between 1999 and 2007, he coordinated surveillance of antimicrobial resistance and antimicrobial consumption in humans in Denmark as part of the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme.
|
From page 471... ...
Dr. Schlundt's main research areas have been epidemiological aspects of Salmonella infection, survival of zoonotic pathogens in the environment, the intestinal microbial colonization process, test methodol ogy for the assessment of genetically modified microorganisms, and microbio logical risk assessment.
|
From page 472... ...
in molecular cell biol ogy-immunology in 1994 from the University of California, Berkeley. He then attended medical school at the Geffen School of Medicine at UCLA, where he received numerous academic honors, including serving as the UCLA Alpha Omega Alpha Chapter Co-President, and winning the prestigious Stafford Warren Award for the top academic performance in his graduating class.
|
From page 473... ...
Weinstein, M.D., is chief operating officer of the outpatient Ruth M Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases, which provides comprehensive primary outpatient care for ~6,000 patients with HIV/AIDS and offers outpatient clinics for sexually transmitted infections, viral hepatitis, and other complicated infectious diseases; Interim Chairman of the Department of Medicine at the John H
|
From page 474... ...
Dr. Wright's laboratory conducts research on the chemical biology of antibi otic resistance, including resistance to aminoglycoside, glycopeptide, and streptogramin families of antibiotics; on the mechanisms of antibiotic biosynthesis; and on the discovery of new antimicrobial targets, in particular antifungal agents.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.